147 related articles for article (PubMed ID: 23463283)
61. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
62. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
63. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
64. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
65. Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression.
Liu Z; Duan ZJ; Chang JY; Zhang ZF; Chu R; Li YL; Dai KH; Mo GQ; Chang QY
PLoS One; 2014; 9(6):e98560. PubMed ID: 24901713
[TBL] [Abstract][Full Text] [Related]
66. miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
Zou Z; Zou R; Zong D; Shi Y; Chen J; Huang J; Zhu J; Chen L; Bao X; Liu Y; Liu W; Huang W; Hu J; Chen Z; Lao X; Chen C; Huang X; Lu Y; Ni X; Fang D; Wu D; Lu S; Jiang M; Qiu C; Wu Y; Qiu Q; Dong Y; Su Y; Zhao C; Zhong Z; Cai J; Liang Y
J Cell Mol Med; 2017 Sep; 21(9):1929-1943. PubMed ID: 28411377
[TBL] [Abstract][Full Text] [Related]
67. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.
Sun Z; Zhao Z; Li G; Dong S; Huang Z; Ye L; Liang H; Qu J; Ai X; Zhang W; Chen X
Tumori; 2010; 96(1):90-6. PubMed ID: 20437864
[TBL] [Abstract][Full Text] [Related]
68. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
69. Suppression of αvβ6 downregulates P-glycoprotein and sensitizes multidrug-resistant breast cancer cells to anticancer drugs.
Zhang YH; Gao ZF; Dong GH; Li X; Wu Y; Li G; Wang AL; Li HL; Yin DL
Neoplasma; 2020 Mar; 67(2):379-388. PubMed ID: 32039627
[TBL] [Abstract][Full Text] [Related]
70. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
71. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
Chen Q; Zhou J; Jiang C; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
[TBL] [Abstract][Full Text] [Related]
72. Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.
Wang Y; Liu L; Liu X; Zhang H; Liu J; Feng B; Shang Y; Zhou L; Wu K; Nie Y; Zhang H; Fan D
Tumour Biol; 2013 Aug; 34(4):2205-14. PubMed ID: 23564482
[TBL] [Abstract][Full Text] [Related]
73. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
Huang C; Cao P; Xie Z; Zhu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
[TBL] [Abstract][Full Text] [Related]
74. Protein kinase Cα protects against multidrug resistance in human colon cancer cells.
Lee SK; Shehzad A; Jung JC; Sonn JK; Lee JT; Park JW; Lee YS
Mol Cells; 2012 Jul; 34(1):61-9. PubMed ID: 22639047
[TBL] [Abstract][Full Text] [Related]
75. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
[TBL] [Abstract][Full Text] [Related]
76. Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes.
Au KW; Kou CY; Woo AY; Chim SS; Fung KP; Cheng CH; Waye MM; Tsui SK
J Cell Biochem; 2006 Jun; 98(3):555-66. PubMed ID: 16440310
[TBL] [Abstract][Full Text] [Related]
77. Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer.
Ge J; Ge C
Virchows Arch; 2019 Jan; 474(1):59-69. PubMed ID: 30267303
[TBL] [Abstract][Full Text] [Related]
78. CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.
Zhao M; Zhang RZ; Qi DW; Chen HY; Zhang GC
Exp Ther Med; 2020 Aug; 20(2):1397-1404. PubMed ID: 32742374
[TBL] [Abstract][Full Text] [Related]
79. [Significance and reversal of MDR1/P-gp in pancreatic cancer chemotherapy].
Guo JC; Zhao YP; Liao Q; Zhu Y
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1488-90. PubMed ID: 18275717
[TBL] [Abstract][Full Text] [Related]
80. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X
J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
